• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

作者信息

van Megen Kayleigh M, van 't Wout Ernst-Jan T, Forman Stephen J, Roep Bart O

机构信息

Department of Diabetes Immunology, Diabetes & Metabolism Research Institute, Beckman Research Institute at the City of Hope, Duarte, CA, United States.

Department of Hematology & Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory, City of Hope Beckman Research Institute and Medical Center, Duarte, CA, United States.

出版信息

Front Immunol. 2018 Apr 6;9:690. doi: 10.3389/fimmu.2018.00690. eCollection 2018.

DOI:10.3389/fimmu.2018.00690
PMID:29696017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5904498/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab06/5904498/026fa83f4737/fimmu-09-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab06/5904498/026fa83f4737/fimmu-09-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab06/5904498/026fa83f4737/fimmu-09-00690-g001.jpg

相似文献

1
A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.1型糖尿病自体造血干细胞移植的未来
Front Immunol. 2018 Apr 6;9:690. doi: 10.3389/fimmu.2018.00690. eCollection 2018.
2
Novel therapy for type 1 diabetes: autologous hematopoietic stem cell transplantation.1 型糖尿病的新型疗法：自体造血干细胞移植。
J Diabetes. 2012 Dec;4(4):332-7. doi: 10.1111/1753-0407.12002.
3
Stem cell therapies for type 1 diabetes mellitus.1型糖尿病的干细胞疗法。
Indian J Exp Biol. 2011 Jun;49(6):395-400.
4
C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.初诊1型糖尿病患者自体非清髓性造血干细胞移植后的C肽水平与胰岛素非依赖状态
JAMA. 2009 Apr 15;301(15):1573-9. doi: 10.1001/jama.2009.470.
5
New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement.1 型糖尿病治疗的新视野：更强化的免疫抑制和β细胞替代。
Front Immunol. 2018 May 17;9:1086. doi: 10.3389/fimmu.2018.01086. eCollection 2018.
6
Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells.自体造血干细胞免疫消融和移植后1型糖尿病患者外源性胰岛素需求的减轻
Pol Arch Med Wewn. 2009 Jun;119(6):422-6.
7
Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.β细胞的免疫原性用于 1 型糖尿病的自体移植。
Pharmacol Res. 2015 Aug;98:60-8. doi: 10.1016/j.phrs.2015.03.003. Epub 2015 Mar 20.
8
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.自体非清髓性造血干细胞移植治疗新诊断的1型糖尿病
JAMA. 2007 Apr 11;297(14):1568-76. doi: 10.1001/jama.297.14.1568.
9
Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.胰岛素依赖型糖尿病的新型疗法：输注体外生成的胰岛素分泌细胞。
Clin Exp Med. 2015 Feb;15(1):41-5. doi: 10.1007/s10238-013-0266-1. Epub 2013 Dec 7.
10
Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.残余β细胞功能可预测自体造血干细胞移植后的临床反应。
Stem Cells Transl Med. 2016 May;5(5):651-7. doi: 10.5966/sctm.2015-0144. Epub 2016 Mar 29.

引用本文的文献

1
Immunomodulatory agents and cell therapy for patients with type 1 diabetes.1型糖尿病患者的免疫调节药物与细胞疗法
Arch Endocrinol Metab. 2025 Apr 11;68:e240233. doi: 10.20945/2359-4292-2024-0233.
2
Correction of T-Cell Repertoire and Autoimmune Diabetes in NOD Mice by Non-myeloablative T-Cell Depleted Allogeneic HSCT.非清髓性 T 细胞清除的同种异体 HSCT 纠正 NOD 小鼠的 T 细胞库和自身免疫性糖尿病。
Stem Cells Transl Med. 2023 May 15;12(5):281-292. doi: 10.1093/stcltm/szad021.
3
Hematopoietic Stem Cells in Type 1 Diabetes.1 型糖尿病中的造血干细胞。

本文引用的文献

1
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.用于严重硬皮病的清髓性自体干细胞移植
N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327.
2
The burden of severe hypoglycemia in type 1 diabetes.1型糖尿病中严重低血糖的负担。
Curr Med Res Opin. 2018 Jan;34(1):171-177. doi: 10.1080/03007995.2017.1391079. Epub 2017 Nov 10.
3
Relapsing/remitting type 1 diabetes.复发缓解型 1 型糖尿病。
Front Immunol. 2021 Jul 9;12:694118. doi: 10.3389/fimmu.2021.694118. eCollection 2021.
4
Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice.嵌合状态的逆转通过混合嵌合实现，从而使糖尿病 NOD 小鼠中的β细胞被重新激活，α细胞发生转分化。
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31219-31230. doi: 10.1073/pnas.2012389117. Epub 2020 Nov 23.
5
Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies.肝移植耐受和诱导耐受的细胞治疗进展。
Front Immunol. 2020 Jun 24;11:1326. doi: 10.3389/fimmu.2020.01326. eCollection 2020.
6
Anti-PD-1 Therapy-Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma.抗 PD-1 治疗相关 1 型糖尿病在复发经典霍奇金淋巴瘤的儿科患者中。
Diabetes Care. 2020 Sep;43(9):2293-2295. doi: 10.2337/dc20-0740. Epub 2020 Jul 2.
7
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?1 型糖尿病 (T1D) 治疗中的最佳耐受原性树突状细胞：我们可以从非肥胖型糖尿病 (NOD) 小鼠模型中学到什么？
Front Immunol. 2019 May 14;10:967. doi: 10.3389/fimmu.2019.00967. eCollection 2019.
8
Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.儿童1型糖尿病的部分临床缓解：临床应用及其定义面临的挑战
Eur Med J Diabetes. 2019 Mar;4(1):89-98. Epub 2019 Mar 14.
Diabetologia. 2017 Nov;60(11):2252-2255. doi: 10.1007/s00125-017-4403-3. Epub 2017 Aug 23.
4
A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.新发儿童1型糖尿病部分临床缓解缺失的预测模型
PLoS One. 2017 May 1;12(5):e0176860. doi: 10.1371/journal.pone.0176860. eCollection 2017.
5
Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.1型糖尿病患者自体造血干细胞移植后的免疫反应。
Stem Cell Res Ther. 2017 Apr 18;8(1):90. doi: 10.1186/s13287-017-0542-1.
6
Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.免疫平衡与1型糖尿病自体造血干细胞移植后的临床结局相关。
Front Immunol. 2017 Feb 22;8:167. doi: 10.3389/fimmu.2017.00167. eCollection 2017.
7
Haematopoietic stem cell transplantation for autoimmune diseases.造血干细胞移植治疗自身免疫性疾病。
Nat Rev Rheumatol. 2017 Apr;13(4):244-256. doi: 10.1038/nrrheum.2017.7. Epub 2017 Feb 23.
8
Risk of death following admission to a UK hospital with diabetic ketoacidosis.因糖尿病酮症酸中毒入住英国医院后的死亡风险。
Diabetologia. 2016 Oct;59(10):2082-7. doi: 10.1007/s00125-016-4034-0. Epub 2016 Jul 11.
9
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.在年龄为 65 岁或以下的套细胞淋巴瘤（MCL Younger）患者中，在自体干细胞移植前给予高剂量阿糖胞苷联合免疫化疗：欧洲套细胞淋巴瘤网络的一项随机、开放标签、3 期试验。
Lancet. 2016 Aug 6;388(10044):565-75. doi: 10.1016/S0140-6736(16)00739-X. Epub 2016 Jun 14.
10
Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.残余β细胞功能可预测自体造血干细胞移植后的临床反应。
Stem Cells Transl Med. 2016 May;5(5):651-7. doi: 10.5966/sctm.2015-0144. Epub 2016 Mar 29.